Nordic Nanovector’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Nordic Nanovector is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of hematological cancers. Read more

Lars Nieba's photo - Interim-CEO of Nordic Nanovector

Interim-CEO

Lars Nieba

CEO Approval Rating

90/100

Founded:

2009

Status:

PublicOtherNANO

Annual Revenue
Employees
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Biosynthema is Nordic Nanovector's biggest rival. Biosynthema was founded in 2001, and is headquartered in Saint Louis, Missouri. Like Nordic Nanovector, Biosynthema also works within the Biotechnology sector. Biosynthema generates $9.6M more revenue vs. Nordic Nanovector.

Immunomedics is one of Nordic Nanovector's top competitors. Immunomedics's headquarters is in Morris Plains, New Jersey, and was founded in 1982. Immunomedics competes in the Pharmaceuticals industry. Immunomedics generates 5,827% of Nordic Nanovector's revenue.

Philogen is seen as one of Nordic Nanovector's top competitors. Philogen is a Private company that was founded in 1996 in Sovicille, Tuscany. Philogen operates in the Retail Distributors industry. Compared to Nordic Nanovector, Philogen has 22 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Agios a competitor of Nordic Nanovector?

Quarterly and Annual Revenue

Coming soon for Nordic Nanovector!

Annual Revenue

$ < 1M

Nordic Nanovector's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 58.3M.

Acquisitions

No recent acquisitions found related to Nordic Nanovector

Nordic Nanovector Funding History

$10.5M$80.4M$139.6M$196.3M

Since Nordic Nanovector was founded in 2009, it has participated in 7 rounds of funding. In total Nordic Nanovector has raised $196.3M. Nordic Nanovector's last funding round was on Oct 2019 for a total of $26.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Oct 2019
$26.4M
-
Private Placement
Mar 2019
$361.3K
-
Private Placement
Feb 2019
$4M
-
Private Placement
Jan 2019
$25.9M
-
Private Placement
Dec 2016
$59.2M
-

Total Funding: $196.3M

Since Nordic Nanovector was founded in 2009, it has participated in 7 rounds of funding. In total Nordic Nanovector has raised $196.3M. Nordic Nanovector's last funding round was on Oct 2019 for a total of $26.4M

Investments

No recent investments found related to Nordic Nanovector

Nordic Nanovector News

August 8, 2020Pharmabiz

IRC recommends Nordic Nanovector to focus on one dosage arm for pivotal PARADIGME phase 2b trial in patients with 3L R/R FL

Nordic Nanovector announced that, following a planned interim analysis of the PARADIGME phase 2b pivo... See more »
July 31, 2020Pharmabiz

Nordic Nanovector gets European patent covering covering the use of Alpha37 to treat CLL & NHL

Nordic Nanovector announced the grant of an EU patent covering the use of Alpha37 for the treatment o... See more »
July 1, 2020Benzinga

Allocation of Restricted Stock Unites (RSUs) to the Board of Directors

OSLO, Norway, July 1, 2020 /PRNewswire/ -- Reference is made to the minutes from Nordic Nanovector AS... See more »
July 1, 2020BioSpace

Nordic Nanovector ASA - Share Capital Increase Registered - July 01, 2020

Reference is made to the stock exchange notice by Nordic Nanovector ASA, of 7 May 2020, regarding the... See more »
June 30, 2020Pharmabiz

US FDA grants fasttrack designation to Nordic Nanovector's Betalutin to treat marginal zone lymphoma

Nordic Nanovector ASA announces that the US Food and Drug Administration (FDA) has granted Fast Track... See more »
June 30, 2020FinanzNachrichten

Nordic Nanovector to Amend PARADIGME Trial Protocol to Expand Eligible Patient Population

OSLO, Norway, June 30, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will ... See more »
June 12, 2020European Biotechnology

Nordic Nanovector in blood cancer pact

Nordic Nanovector Press Releases

May 7, 2020centralcharts

Increase of Share Capital

October 24, 2019StreetInsider

Nordic Nanovector ASA - Resolution not to Proceed With a Repair Offering

OSLO, Norway, Oct. 24, 2019 /PRNewswire/ -- Reference is made to the stock exchange announcement on 1... See more »
April 4, 2019CentralCharts

Notice of Annual General Meeting on 25 April 2019

OSLO, Norway, April 4, 2019 /PRNewswire/ -- Notice is given that the Annual General Meeting of Nordic... See more »
April 4, 2019CentralCharts

Notice of Annual General Meeting on 25 April 2019

OSLO, Norway, April 4, 2019 /PRNewswire/ -- Notice is given that the Annual General Meeting of Nordic... See more »
April 3, 2019CentralCharts

Nordic Nanovector ASA Publishes 2018 Annual Report

Nordic Nanovector ASA has today published its 2018 Annual Report, including the complete 2018 Annual ... See more »
January 24, 2019StreetInsider

NANO) Nomination Committee Proposes New Chairman

In the nomination committee's recommendation to the Company's annual general meeting in 2018, it was ... See more »
November 27, 2018centralcharts

Increased Share Capital Following Exercise of Employee Share Options

An individual participant in Nordic Nanovector ASA's (the "Company") (OSE:NANO) previous share option... See more »

Nordic Nanovector Videos

Headquarters

Kjelsasveien 168 B

Oslo, Oslo0884

47-22-18-33-01

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Nordic Nanovector is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of hematological cancers. Nordic Nanovector was founded in 2009. Nordic Nanovector's headquarters is located in Oslo, Oslo, NO 0884....

CEO

Nordic Nanovector's Interim-CEO, Lars Nieba, currently has an approval rating of 90%. Nordic Nanovector's primary competitors are Biosynthema, Immunomedics & Philogen.

Website

nordicnanovector.com

Frequently Asked Questions about Nordic Nanovector

  1. When was Nordic Nanovector founded?

    Nordic Nanovector was founded in 2009
  2. Who is Nordic Nanovector's CEO?

    Nordic Nanovector's CEO is Lars Nieba
  3. How much revenue does Nordic Nanovector generate?

    Nordic Nanovector generates $ < 1M in revenue
  4. How much funding does Nordic Nanovector have?

    Nordic Nanovector has historically raised $196.3M in funding
  1. Where is Nordic Nanovector's headquarters?

    Nordic Nanovector's headquarters is in Oslo Oslo, NO
  2. How many employees does Nordic Nanovector have?

    Nordic Nanovector has 48 employees
  3. What sector does Nordic Nanovector operate in?

    Nordic Nanovector is in Biotechnology
  4. Who are Nordic Nanovector's competitors?

    Nordic Nanovector's top competitors are Biosynthema, Immunomedics, Philogen